PubMed HealthSearch

PubMed · 3553018

Massive transfusion.

Abstract

The physiological stress of anesthesia, hemorrhage, and operation can all contribute to postoperative morbidity and mortality in the patient who has experienced massive trauma. However, the problems of massive transfusion are not insurmountable. More important than achieving an adequate blood pressure in the hemorrhaging patient is the need to reestablish adequate tissue perfusion, thus maintaining oxygen transport and appropriate tissue oxygen consumption. Oxygen consumption will decrease after hemorrhagic shock, reflecting a metabolic deficit at the cellular level, and may contribute to end-organ failure. Through blood transfusion, the oxygen consumptive needs of the tissues can be met. Whether the blood administered is autologous or homologous, no superior medium for oxygen transport is yet available. Close attention to the hazards associated with massive transfusion will result in improved outcome and decreased mortality.

Explore related subjects

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

A Patterson. 1987. Massive transfusion.. https://doi.org/10.1097/00004311-198702510-00006

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related citations

Autologous blood transfusion in Auckland.

AIMS: To review autologous blood collection and transfusion practice in Auckland over the last five years. METHOD: Records of autologous blood collections were obtained from blood collection centre records and results of transfusions on patients from hospital notes. RESULTS: One hundred and sixty-four units of blood were collected from 77 patients. Seventy-five percent of the units collected were transfused. Most autologous blood was transfused to private hospital patients. Only 8% of patients required homologous blood. CONCLUSIONS: There has been a slow increase of autologous blood collection and transfusion in the Auckland area, as well as in the rest of New Zealand. The present risks of homologous transfusion, particularly since the introduction of hepatitis C testing, appear very low. A further expansion of the present autologous blood programme would entail increased expenditure and it is suggested that a critical cost benefit analysis would be useful before the programme is expanded.

Blood Transfusion